
|Articles|April 2, 2014
Cancer Centers Must Promote Culture in Support of Reimbursement for Clinical Trials
Author(s)David Evans, RN, MSN, MBA
At the ACCC 40th Annual National Meeting, David Evans, RN, MSN, MBA, discussed some of the top reimbursement issues that cancer centers face when it some to clinical trials.
Advertisement
At the ACCC 40th Annual National Meeting, David Evans, RN, MSN, MBA, discussed some of the top reimbursement issues that cancer centers face when it some to clinical trials. Evans says that an organization that is committed to offering clinical trials as treatment options should have, or needs to develop, a culture and infrastructure that promotes enrollments, supports patients in dealing with third-party payers, and challenges anyone who threatens to withhold reimbursement for the routine cost of cancer care.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Belzutifan Combo Improves Disease Control Vs Cabozantinib in Advanced RCC
2
Lymphoma's Revolution: Evens & Rhodes on CLL, CAR-T, and NJ Care
3
Novel Cancer Vaccine Meets Primary, Secondary End Points in Resected Melanoma
4
Choosing Between Approved Frontline Metastatic Pancreatic Cancer Regimens
5




















































